While this is not documented with Irbesartan BMS, a similar effect should be anticipated with angiotensin-II receptor antagonists.
Kuigi seda ei ole dokumenteeritud Irbesartan BMS' i puhul, tuleb arvestada angiotensiin- II retseptorite antagonistide samasuguse toimega.